Glucose-Lowering Therapy Delayed for Newly Diagnosed T2DM Patients

TUESDAY, July 6, 2021 -- For adults newly diagnosed with type 2 diabetes mellitus (T2DM), delays to first-line therapy are longest for older patients, those who are Black or of other ethnicities, and those with multimorbidity, according to a study...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news